UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

AIDS (London), 2010-11, Vol.24 (18), p.2827-2833

2010

Volltextzugriff (PDF)

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV

PloS one, 2020-09, Vol.15 (9), p.e0238575-e0238575

2020

Volltextzugriff (PDF)

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

PloS one, 2014-02, Vol.9 (2), p.e84676

2014

Volltextzugriff (PDF)

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

Journal of antimicrobial chemotherapy, 2018-09, Vol.73 (9), p.2452-2459

2018

Volltextzugriff (PDF)

Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan

PloS one, 2012-10, Vol.7 (10), p.e46031-e46031

2012

Volltextzugriff (PDF)

Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression

Clinical infectious diseases, 2002-02, Vol.34 (4), p.504-510

2002

Volltextzugriff (PDF)

Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study

Medicine (Baltimore), 2016-08, Vol.95 (32), p.e4507

2016

Volltextzugriff (PDF)

Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen

AIDS (London), 2006-10, Vol.20 (16), p.2075-2080

2006

Volltextzugriff (PDF)

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity

BioMed research international, 2016-01, Vol.2016, p.4380845-5

2016

Volltextzugriff (PDF)

Cambios en los hábitos alimentarios de los pacientes infectados por el VIH a través del asesoramiento gastronómico y talleres de adquisición de habilidades culinarias (Estudio ALÍCIA-FLS)

Revista Española de Nutrición Humana y Dietética, 2015, Vol.19 (3), p.184-186

2015

Volltextzugriff (PDF)

Compromised Immunologic Recovery in Treatment-Experienced Patients with HIV Infection Receiving Both Tenofovir Disoproxil Fumarate and Didanosine in the TORO Studies

Clinical infectious diseases, 2005-09, Vol.41 (6), p.901-905

2005

Volltextzugriff (PDF)

High Prevalence of Sarcopenia in HIV-Infected Individuals

BioMed research international, 2018-01, Vol.2018, p.5074923-5

2018

Volltextzugriff (PDF)

Management of bone mineral density in HIV-infected patients

Expert opinion on pharmacotherapy, 2016-04, Vol.17 (6), p.845-852

2016

Volltextzugriff (PDF)

Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients

Clinical rheumatology, 2016-05, Vol.35 (5), p.1271-1279

2016

Volltextzugriff (PDF)

Potential prescribing issues among older HIV‐infected subjects in a Mediterranean cohort: Does the current prevalence give cause for concern?

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.1310-1317

2021

Volltextzugriff (PDF)

A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction

Telemedicine journal and e-health, 2021-04, Vol.27 (4), p.432

2021

Volltextzugriff (PDF)

Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV

HIV medicine, 2022-11, Vol.23 (10), p.1078-1084

2022

Volltextzugriff (PDF)

Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals

Medicine (Baltimore), 2017-09, Vol.96 (37), p.e7421-e7421

2017

Volltextzugriff (PDF)

Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)

Journal of antimicrobial chemotherapy, 2014-12, Vol.69 (12), p.3368-3371

2014

Volltextzugriff (PDF)

Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease

Antimicrobial agents and chemotherapy, 2016-04, Vol.60 (4), p.2564-2566

2016

Volltextzugriff (PDF)

Accentuated aging associated with HIV in a Mediterranean setting occurs mainly in persons aged>70 years: a comparative cohort study (Over50 cohort)

AIDS care, 2022-02, Vol.34 (2), p.155-162

2022

Volltextzugriff (PDF)

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels

Journal of antimicrobial chemotherapy, 2015-07, Vol.70 (7), p.2104-2107

2015

Volltextzugriff (PDF)

Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population

Journal of acquired immune deficiency syndromes (1999), 2014-01, Vol.65 (1), p.50

2014

Volltextzugriff (PDF)

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy

Antiviral research, 2012-10, Vol.96 (1), p.65-69

2012

Volltextzugriff (PDF)

Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial

Journal of antimicrobial chemotherapy, 2013-06, Vol.68 (6), p.1382-1387

2013

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(68)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Humans
(51)
Life Sciences & Biomedicine
(48)
Male
(38)
Female
(37)
Human Immunodeficiency Virus
(37)
Hiv Infections - Drug Therapy
(35)
Infectious Diseases
(35)
Adult
(33)
Middle Aged
(33)
Hiv
(31)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Immunology
(20)
Viral Diseases
(20)
Hiv Infections - Virology
(19)
Human Viral Diseases
(19)
Virology
(19)
Microbiology
(18)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan

Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression

Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study

Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity

Cambios en los hábitos alimentarios de los pacientes infectados por el VIH a través del asesoramiento gastronómico y talleres de adquisición de habilidades culinarias (Estudio ALÍCIA-FLS)

Compromised Immunologic Recovery in Treatment-Experienced Patients with HIV Infection Receiving Both Tenofovir Disoproxil Fumarate and Didanosine in the TORO Studies

High Prevalence of Sarcopenia in HIV-Infected Individuals

Management of bone mineral density in HIV-infected patients

Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients

Potential prescribing issues among older HIV‐infected subjects in a Mediterranean cohort: Does the current prevalence give cause for concern?

A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction

Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV

Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals

Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)

Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease

Accentuated aging associated with HIV in a Mediterranean setting occurs mainly in persons aged>70 years: a comparative cohort study (Over50 cohort)

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels

Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy

Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial

Suchergebnisse filtern